SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-136755
Filing Date
2005-07-01
Accepted
2005-07-01 15:51:40
Documents
4
Period of Report
2005-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 13222
2 NON-EMPLOYEE DIRECTOR DEFERRED COMPENSATION PROGRAM dex101.htm EX-10.1 75947
3 FORM OF DEFERRED STOCK UNIT AWARD AGREEMENT dex102.htm EX-10.2 7643
4 GRAPHIC g24116logo.jpg GRAPHIC 10835
  Complete submission text file 0001193125-05-136755.txt   113314
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 05933233
SIC: 2836 Biological Products, (No Diagnostic Substances)